全文获取类型
收费全文 | 110096篇 |
免费 | 8644篇 |
国内免费 | 433篇 |
专业分类
耳鼻咽喉 | 1219篇 |
儿科学 | 3113篇 |
妇产科学 | 1789篇 |
基础医学 | 14360篇 |
口腔科学 | 1503篇 |
临床医学 | 11297篇 |
内科学 | 23572篇 |
皮肤病学 | 1427篇 |
神经病学 | 10105篇 |
特种医学 | 4052篇 |
外科学 | 17442篇 |
综合类 | 1713篇 |
一般理论 | 105篇 |
预防医学 | 8035篇 |
眼科学 | 3251篇 |
药学 | 7721篇 |
1篇 | |
中国医学 | 227篇 |
肿瘤学 | 8241篇 |
出版年
2023年 | 879篇 |
2022年 | 1381篇 |
2021年 | 3162篇 |
2020年 | 1826篇 |
2019年 | 2888篇 |
2018年 | 3311篇 |
2017年 | 2375篇 |
2016年 | 2553篇 |
2015年 | 2961篇 |
2014年 | 4227篇 |
2013年 | 5288篇 |
2012年 | 8437篇 |
2011年 | 8768篇 |
2010年 | 4853篇 |
2009年 | 4250篇 |
2008年 | 7150篇 |
2007年 | 7303篇 |
2006年 | 6783篇 |
2005年 | 6645篇 |
2004年 | 6171篇 |
2003年 | 5598篇 |
2002年 | 5051篇 |
2001年 | 1726篇 |
2000年 | 1420篇 |
1999年 | 1448篇 |
1998年 | 1091篇 |
1997年 | 823篇 |
1996年 | 685篇 |
1995年 | 643篇 |
1994年 | 587篇 |
1993年 | 560篇 |
1992年 | 766篇 |
1991年 | 679篇 |
1990年 | 618篇 |
1989年 | 568篇 |
1988年 | 524篇 |
1987年 | 467篇 |
1986年 | 464篇 |
1985年 | 471篇 |
1984年 | 404篇 |
1983年 | 356篇 |
1982年 | 377篇 |
1981年 | 339篇 |
1980年 | 276篇 |
1979年 | 255篇 |
1978年 | 207篇 |
1977年 | 206篇 |
1976年 | 139篇 |
1975年 | 120篇 |
1974年 | 133篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
993.
994.
Fong Zhi Ven Sekigami Yurie Qadan Motaz Fernandez-del Castillo Carlos Warshaw Andrew L. Lillemoe Keith D. Ferrone Cristina R. 《Annals of surgical oncology》2021,28(8):4216-4224
Annals of Surgical Oncology - Long-term pancreatoduodenectomy (PD) survivors have previously reported favorable quality of life (QoL). However, there has been a paucity of studies utilizing... 相似文献
995.
Angela B. Smith Cleo A. Samuel Sean D. McCabe Allison Deal Mattias Jonsson Dana E. Mueller Zahra M. Mahbooba Antonia V. Bennett Arlene E. Chung Matthew E. Nielsen Hung-Jui Tan Eric Wallen Raj Pruthi Andrew Wang Ethan Basch Bryce B. Reeve Ronald C. Chen 《Urologic oncology》2021,39(1):77.e1-77.e8
ObjectiveTo assess the feasibility of enrollment and collecting patient-reported outcome (PRO) data as part of routine clinical urologic care for bladder and prostate cancer patients and examine overall patterns and racial variations in PRO use and symptom reports over time.Subjects/Patients and MethodsWe recruited 76 patients (n = 29 Black and n = 47 White) with prostate or bladder cancer at a single, comprehensive cancer center. The majority of prostate cancer patients had intermediate risk (57%) disease and underwent either radiation or prostatectomy. Over half (58%) of bladder cancer patients had muscle invasive disease and underwent cystectomy.Patients were asked to complete PRO symptom surveys using their preferred mode [web- or phone-based interactive voice response (IVR)]. Symptom summary reports were shared with providers during visits. Surveys were completed at 3 time points and assessed urinary, sexual, gastrointestinal, anxiety/depression, and sleep symptoms. Feasibility of enrollment and survey completion were calculated, and linear mixed effects models estimated differences in outcomes by race and time.ResultsSixty three percent of study participants completed all PRO measures at all 3 time points. Black patients were more likely to select IVR as their survey mode (40% vs. 13%, P < 0.05), and less likely to complete all surveys (55% vs. 74%, P = 0.13). Patients using IVR were also less likely to complete all surveys (41% vs. 69%, P = 0.046).ConclusionsReported preferences for survey mode and completion rates differ by race, which may influence survey completion rates and highlight potential obstacles for equitable implementation of PROs into clinical care. 相似文献
996.
Patrick M. Lec Abhishek Venkataramana Andrew T. Lenis Katherine E. Fero Vidit Sharma Vishnukamal Golla Kiran Gollapudi Jeremy Blumberg Karim Chamie 《Urologic oncology》2021,39(3):194.e17-194.e24
BackgroundHigh-risk ureteral tumors represent an understudied subset of upper tract urothelial carcinoma, whose surgical management can range from a radical nephroureterectomy (NU) to segmental ureterectomy (SU).ObjectivesTo evaluate contemporary trends in the management of high-risk ureteral tumors, the utilization of lymphadenectomy and peri-operative chemotherapy, and their impact on overall survival (OS).Design, setting, and participantsWe performed a retrospective cohort study of patients in the National Cancer Database from years 2006 to 2013 with clinically localized high-risk ureteral tumors treated with NU or SU.Outcome measurements and statistical analysisChi-squared tests were utilized to assess differences in clinicodemographic features and peri-operative treatment delivery between SU and NU cohorts. Cochran-Armitage tests and linear regressions were performed to evaluate temporal trends in treatment utilization. Multivariable logistic regression models were employed to assess predictors of treatment delivery. Multivariable Cox proportional hazards models evaluated associations with OS.ResultsOf the 1,962 patients included, NU was more commonly performed than SU (72.4%, 1,421/1,962 vs. 27.6%, 541/1,962). Only 22.7% (446/1,962) of the population underwent lymphadenectomy, and 24.8% (271/1,092) of those with advanced pathology (≥pT2 or pN+) received adjuvant chemotherapy. Lymphadenectomy was associated with improved OS in NU patients when more than 3 nodes were removed (hazard ratio [HR] 0.58, 95% confidence interval [CI] 0.39–0.89). Receipt of adjuvant chemotherapy for advanced pathology had no impact OS in both the NU (HR 1.10, 95% CI 0.84–1.44) and SU (HR 0.94, 95% CI 0.61–1.46) cohorts. Performance of SU was not associated with poorer OS on multivariable analysis (HR 1.02, 95% CI 0.89–1.21, P = 0.83).ConclusionOur study suggests that SU may be an appropriate alternative to NU for the management of high-risk ureteral tumors. Further, lymphadenectomy may play an important role at the time of NU, and adjuvant chemotherapy is infrequently utilized in patients with advanced pathology. 相似文献
997.
Andrew Fisher Alistair Bond Matthew D.G. Philpott Malwattage Lara Tania Jayatilaka Laura-Ann Lambert Lauren Fisher Lizzy Weigelt Darren Myatt Andrew Molloy Lyndon Mason 《Foot and Ankle Surgery》2021,27(3):291-295
BackgroundOur aim in this study was to identify the fibular footprint of the Anterior Inferior Tibiofibular Ligament (AITFL) and its relation to Wagstaffe fracture fragment size.MethodsWe examined 25 cadaveric lower limbs which were carefully dissected to identify the lateral ankle ligaments. The AITFL anatomy was compared to 40 Wagstaffe fractures identified from our ankle fracture database.ResultsThe AITFL origin was from the anterior fibular tubercle with an average length of 21.61 mm (95% CI 20.22, 22.99). The average distance of the distal aspect of the AITFL footprint to the distal fibula margin was 11.60 mm (95% CI 10.49, 12.71). In the ankle fractures analyzed, the average length of the Wagstaffe fragment was 17.88 mm (95% CI 16.21, 19.54). The average distance from the distal tip of the fibula to the Wagstaffe fracture fragment was 21.40 mm (95% CI 19.78, 23.01).In total there were 22 syndesmosis injuries. There was no statistical difference in Wagstaffe fragment size between stable and unstable groups.ConclusionThe AITFL fibular origin was both larger and more distal than the Wagstaffe fracture fragments seen in our institution. Therefore, this suggests that a ligamentous failure will also have to occur to result in syndesmotic instability. The size of fracture fragment also did not confer to syndesmotic instability on testing.Level of Evidence - 3 相似文献
998.
999.
1000.
Zach Pennington Jeff Ehresman James Feghali Andrew Schilling Andrew Hersh Bethany Hung Daniel Lubelski Daniel M. Sciubba 《The spine journal》2021,21(2):302-311
BACKGROUND CONTEXTSurgery for vertebral column tumors is commonly associated with intraoperative blood loss (IOBL) exceeding 2 liters and the need for transfusion of allogeneic blood products. Transfusion of allogeneic blood, while necessary, is not benign, and has been associated with increased rates of wound complication, venous thromboembolism, delirium, and death.PURPOSETo develop a prediction tool capable of predicting IOBL and risk of requiring allogeneic transfusion in patients undergoing surgery for vertebral column tumors.STUDY DESIGN/SETTINGRetrospective, single-center study.PATIENT SAMPLEConsecutive series of 274 patients undergoing 350 unique operations for primary or metastatic spinal column tumors over a 46-month period at a comprehensive cancer centerOUTCOME MEASURESIOBL (in mL), use of intraoperative blood products, and intraoperative blood products transfused.METHODSWe identified IOBL and transfusions, along with demographic data, preoperative laboratory data, and surgical procedures performed. Independent predictors of IOBL and transfusion risk were identified using multivariable regression.RESULTSMean age at surgery was 57.0±13.6 years, 53.1% were male, and 67.1% were treated for metastatic lesions. Independent predictors of IOBL included en bloc resection (p<.001), surgical invasiveness (β=25.43 per point; p<0.001), and preoperative albumin (β=?244.86 per g/dL; p=0.011). Predictors of transfusion risk included preoperative hematocrit (odds ratio [OR]=0.88 per %; 95% confidence interval [CI, 0.84, 0.93]; p<0.001), preoperative MCHgb (OR=0.88 per pg; 95% CI [0.78, 1.00]; p=0.048), preoperative red cell distribution width (OR=1.32 per %; 95% CI [1.13, 1.55]; p<0.001), en bloc resection (OR=3.17; 95%CI [1.33, 7.54]; p=0.009), and surgical invasiveness (OR=1.08 per point; [1.06; 1.11]; p<0.001). The transfusion model showed a good fit of the data with an optimism-corrected area under the curve of 0.819. A freely available, web-based calculator was developed for the transfusion risk model (https://jhuspine3.shinyapps.io/TRUST/).CONCLUSIONSHere we present the first clinical calculator for intraoperative blood loss and transfusion risk in patients being treated for primary or metastatic vertebral column tumors. Surgical invasiveness and preoperative microcytic anemia most strongly predict transfusion risk. The resultant calculators may prove clinically useful for surgeons counseling patients about their individual risk of requiring allogeneic transfusion. 相似文献